Author | Richard G. Stock, MD | OncLive

Author | Richard G. Stock, MD

Articles

Dr. Stock on the Optimal Use of Radium-223 in mCRPC

April 25, 2016

Video

Richard G. Stock, MD, senior faculty, Radiation Oncology, Mount Sinai Hospital, discusses the optimal use of radium-223 dichloride (Xofigo) for the treatment of patients with metastatic castration-resistant prostate cancer.

x